Regeneron Pharmaceuticals (REGN)

Long-Term Debt

$1.99B

Quarterly · Period ending: · USD

REGN logo

REGN Long-Term Debt

Latest reported$1.99B
REGN Quarterly Long-Term Debt ($0.00 → $1.99B)
High-resolution chart · PNG

REGN long-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Long-Term Debt — Quarterly (USD)
Period endingLong-Term Debt (USD)
1,986,600,000
1,986,200,000
2,705,900,000
2,705,500,000
2,705,100,000
2,704,800,000
2,704,400,000
2,704,000,000
2,703,600,000
2,703,300,000
2,702,900,000
2,702,600,000
2,702,200,000
2,701,800,000
2,701,400,000
2,701,100,000
2,700,700,000
2,700,400,000
1,980,000,000
1,979,600,000
1,979,200,000
1,978,900,000
2,695,700,000
2,694,800,000
715,900,000
715,200,000
713,900,000
712,700,000
711,300,000
709,900,000
708,500,000
707,203,000
705,903,000
704,645,000
703,500,000
702,317,000
701,173,000
700,407,000
351,569,000
382,228,000
361,523,000
362,230,000
362,919,000
394,867,000
388,047,000
472,476,000
457,711,000
564,062,000
516,786,000
530,053,000
504,573,000
481,381,000
472,508,000
461,275,000
455,954,000
450,458,000
445,049,000
439,740,000
434,527,000
159,482,000
159,457,000
159,353,000
159,355,000
158,382,000
157,359,000
156,464,000
109,022,000
62,571,000
62,925,000
0
5,093,000
0
0
0
0
200,000,000
200,000,000
200,000,000
200,000,000
200,000,000
200,000,000
200,000,000
200,000,000
200,000,000
200,000,000
200,000,000
200,000,000
200,000,000
200,000,000
200,000,000
200,000,000
200,000,000
200,000,000
200,000,000
200,000,000
200,000,000
200,000,000
200,053,000
200,150,000
1,646,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.